• PoP liposomes
  • Photothermal therapy using organic nanoparticles
  • Nanoparticle degradation in vivo
  • Biocompatible, porphyrin cross-linked polymers
  • Photodynamic molecular beacons
PoP-liposomes1 Photothermal therapy using organic nanoparticles2 Nanoparticle degradation in vivo3 Biocompatible, porphyrin cross-linked polymers4 Photodynamic molecular beacons5

About the Lovell lab

The lab was established at University at Buffalo's new Biomedical Engineering department in 2012. Broadly, our focus is on developing novel nanomedicine approaches to meet unmet needs in treating and diagnosing disease. We strive to use engineering principles to iteratively design, synthesize, characterize, test and validate next generation nanoparticles and biosensors with the ultimate goal of making a translational impact on improving human health. Developing safer, organic nanoparticles that will allow superior treatment options for cancer therapy is a major research thrust.